vs

Side-by-side financial comparison of FIRST FINANCIAL BANKSHARES INC (FFIN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

FIRST FINANCIAL BANKSHARES INC is the larger business by last-quarter revenue ($164.7M vs $83.1M, roughly 2.0× PROCEPT BioRobotics Corp). FIRST FINANCIAL BANKSHARES INC runs the higher net margin — 44.5% vs -38.1%, a 82.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 12.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.7%).

First Financial Bank is a regional bank operated by First Financial Corporation and based in Terre Haute, Indiana. It is the oldest national bank in Indiana and the fifth oldest national bank in the United States. First Financial Corporation is Vigo County's only publicly traded company.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FFIN vs PRCT — Head-to-Head

Bigger by revenue
FFIN
FFIN
2.0× larger
FFIN
$164.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+8.2% gap
PRCT
20.2%
12.0%
FFIN
Higher net margin
FFIN
FFIN
82.6% more per $
FFIN
44.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.7%
FFIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FFIN
FFIN
PRCT
PRCT
Revenue
$164.7M
$83.1M
Net Profit
$73.3M
$-31.6M
Gross Margin
64.9%
Operating Margin
54.4%
-4.1%
Net Margin
44.5%
-38.1%
Revenue YoY
12.0%
20.2%
Net Profit YoY
17.6%
-27.9%
EPS (diluted)
$0.51
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIN
FFIN
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$164.7M
$76.4M
Q3 25
$161.3M
$83.3M
Q2 25
$156.6M
$79.2M
Q1 25
$149.0M
$69.2M
Q4 24
$147.1M
$68.2M
Q3 24
$139.5M
$58.4M
Q2 24
$134.5M
$53.4M
Net Profit
FFIN
FFIN
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$73.3M
$-29.8M
Q3 25
$52.3M
$-21.4M
Q2 25
$66.7M
$-19.6M
Q1 25
$61.3M
$-24.7M
Q4 24
$62.3M
$-18.9M
Q3 24
$55.3M
$-21.0M
Q2 24
$52.5M
$-25.6M
Gross Margin
FFIN
FFIN
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
FFIN
FFIN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
54.4%
-40.6%
Q3 25
39.2%
-27.8%
Q2 25
52.2%
-28.0%
Q1 25
50.4%
-39.7%
Q4 24
51.7%
-28.9%
Q3 24
48.3%
-38.4%
Q2 24
47.3%
-50.3%
Net Margin
FFIN
FFIN
PRCT
PRCT
Q1 26
-38.1%
Q4 25
44.5%
-39.1%
Q3 25
32.4%
-25.7%
Q2 25
42.6%
-24.7%
Q1 25
41.2%
-35.8%
Q4 24
42.4%
-27.6%
Q3 24
39.7%
-35.9%
Q2 24
39.0%
-48.0%
EPS (diluted)
FFIN
FFIN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.51
$-0.54
Q3 25
$0.36
$-0.38
Q2 25
$0.47
$-0.35
Q1 25
$0.43
$-0.45
Q4 24
$0.43
$-0.34
Q3 24
$0.39
$-0.40
Q2 24
$0.37
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIN
FFIN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.9B
$347.7M
Total Assets
$15.4B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIN
FFIN
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
FFIN
FFIN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
FFIN
FFIN
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$1.9B
$365.9M
Q3 25
$1.8B
$380.3M
Q2 25
$1.7B
$385.8M
Q1 25
$1.7B
$389.2M
Q4 24
$1.6B
$402.2M
Q3 24
$1.7B
$241.2M
Q2 24
$1.5B
$251.8M
Total Assets
FFIN
FFIN
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$15.4B
$508.1M
Q3 25
$14.8B
$511.5M
Q2 25
$14.4B
$513.1M
Q1 25
$14.3B
$519.4M
Q4 24
$14.0B
$534.0M
Q3 24
$13.6B
$374.1M
Q2 24
$13.2B
$374.4M
Debt / Equity
FFIN
FFIN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIN
FFIN
PRCT
PRCT
Operating Cash FlowLast quarter
$299.4M
Free Cash FlowOCF − Capex
$286.0M
FCF MarginFCF / Revenue
173.6%
Capex IntensityCapex / Revenue
8.2%
Cash ConversionOCF / Net Profit
4.08×
TTM Free Cash FlowTrailing 4 quarters
$503.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIN
FFIN
PRCT
PRCT
Q1 26
Q4 25
$299.4M
$-10.3M
Q3 25
$86.5M
$-6.6M
Q2 25
$61.3M
$-15.0M
Q1 25
$76.8M
$-17.0M
Q4 24
$309.6M
$-32.4M
Q3 24
$80.7M
$-18.8M
Q2 24
$68.8M
$-15.7M
Free Cash Flow
FFIN
FFIN
PRCT
PRCT
Q1 26
Q4 25
$286.0M
$-12.2M
Q3 25
$83.7M
$-9.5M
Q2 25
$58.7M
$-17.8M
Q1 25
$74.7M
$-18.8M
Q4 24
$292.9M
$-33.6M
Q3 24
$77.7M
$-19.0M
Q2 24
$63.8M
$-16.8M
FCF Margin
FFIN
FFIN
PRCT
PRCT
Q1 26
Q4 25
173.6%
-15.9%
Q3 25
51.9%
-11.4%
Q2 25
37.5%
-22.5%
Q1 25
50.1%
-27.2%
Q4 24
199.1%
-49.2%
Q3 24
55.7%
-32.6%
Q2 24
47.4%
-31.4%
Capex Intensity
FFIN
FFIN
PRCT
PRCT
Q1 26
Q4 25
8.2%
2.4%
Q3 25
1.7%
3.4%
Q2 25
1.6%
3.5%
Q1 25
1.4%
2.7%
Q4 24
11.4%
1.7%
Q3 24
2.2%
0.4%
Q2 24
3.7%
2.0%
Cash Conversion
FFIN
FFIN
PRCT
PRCT
Q1 26
Q4 25
4.08×
Q3 25
1.65×
Q2 25
0.92×
Q1 25
1.25×
Q4 24
4.97×
Q3 24
1.46×
Q2 24
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FFIN
FFIN

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons